| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/31/2023 | Seagen Inc. | SGEN | Grant | | 2k | $0.00 | $0 | | 05/31/2023 |
| 04/03/2023 | Syros Pharmaceuticals, Inc. | SYRS | Payment of Exercise | Common Stock | 1.9k | $2.58 | $4.8k | | 03/31/2023 |
| 03/31/2023 | Syros Pharmaceuticals, Inc. | SYRS | Exercise | Restricted Stock Units | 6k | $0.00 | $0 | | 03/31/2023 |
| 12/12/2022 | Seagen Inc. | SGEN | Exercise | Non-Qualified Stock Option (right to buy) | 8.8k | $36.70 | $321.1k | | 12/12/2022 |
| 10/06/2022 | Syros Pharmaceuticals, Inc. | SYRS | Grant | Restricted Stock Units | 80.2k | $0.00 | $0 | | 10/06/2022 |
| 10/06/2022 | Syros Pharmaceuticals, Inc. | SYRS | Grant | Stock Option (right to buy) | 115k | $6.73 | $774k | | 10/06/2022 |
| 05/13/2022 | Seagen Inc. | SGEN | Grant | Common Stock | 1.5k | $0.00 | $0 | | 05/13/2022 |
| 05/13/2022 | Seagen Inc. | SGEN | Grant | Non-Qualified Stock Option (right to buy) | 3.7k | $135.63 | $498.6k | | 05/13/2022 |
| 04/01/2022 | Syros Pharmaceuticals, Inc. | SYRS | Payment of Exercise | Common Stock | 58.9k | $1.12 | $65.9k | | 04/01/2022 |
| 03/02/2022 | Seagen Inc. | SGEN | Exercise | Non-Qualified Stock Option (right to buy) | 25k | $20.04 | $501k | | 03/02/2022 |
| 02/15/2022 | Syros Pharmaceuticals, Inc. | SYRS | Grant | Stock Option (right to buy) | 375k | $1.59 | $596.2k | | 02/15/2022 |
| 02/15/2022 | Syros Pharmaceuticals, Inc. | SYRS | Grant | Restricted Stock Units | 240k | $0.00 | $0 | | 02/15/2022 |
| 02/15/2022 | Syros Pharmaceuticals, Inc. | SYRS | Grant | Restricted Stock Units | 400k | $0.00 | $0 | | 02/15/2022 |
| 05/14/2021 | Seagen Inc. | SGEN | Grant | | 1.4k | $0.00 | $0 | | 05/14/2021 |
| 05/14/2021 | Seagen Inc. | SGEN | Grant | Non-Qualified Stock Option (right to buy) | 3.5k | $147.50 | $510.6k | | 05/14/2021 |
| 02/17/2021 | Syros Pharmaceuticals, Inc. | SYRS | Grant | Stock Option (right to buy) | 304k | $11.41 | $3.5M | | 02/17/2021 |
| 12/18/2020 | Syros Pharmaceuticals, Inc. | SYRS | Exercise | Stock Option (right to buy) | 10.8k | $3.04 | $32.7k | | 12/18/2020 |
| 12/18/2020 | Syros Pharmaceuticals, Inc. | SYRS | Exercise | Stock Option (right to buy) | 14.2k | $8.51 | $120.6k | | 12/18/2020 |
| 12/18/2020 | Syros Pharmaceuticals, Inc. | SYRS | Exercise | Stock Option (right to buy) | 5k | $10.09 | $50.3k | | 12/18/2020 |
| 06/17/2020 | Evelo Biosciences, Inc. | EVLO | Grant | Stock Option (Right to Buy) | 15.7k | $3.59 | $56.3k | | 06/17/2020 |
| 05/15/2020 | Seagen Inc. | SGEN | Grant | Non-Qualified Stock Option (right to buy) | 3.2k | $160.33 | $508.4k | | 05/15/2020 |
| 05/15/2020 | Seagen Inc. | SGEN | Grant | | 1.3k | $0.00 | $0 | | 05/15/2020 |
| 02/13/2020 | Syros Pharmaceuticals, Inc. | SYRS | Grant | Stock Option (right to buy) | 294k | $7.54 | $2.2M | | 02/13/2020 |
| 12/23/2019 | Syros Pharmaceuticals, Inc. | SYRS | Exercise | Stock Option (right to buy) | 33.4k | $3.04 | $101.6k | | 12/23/2019 |
| 12/23/2019 | Syros Pharmaceuticals, Inc. | SYRS | Exercise | Stock Option (right to buy) | 10.8k | $3.04 | $32.7k | | 12/23/2019 |
| 12/23/2019 | Syros Pharmaceuticals, Inc. | SYRS | Exercise | Stock Option (right to buy) | 8.2k | $3.04 | $25k | | 12/23/2019 |
| 06/12/2019 | Evelo Biosciences, Inc. | EVLO | Grant | Stock Option (Right to Buy) | 15.7k | $7.07 | $110.9k | | 06/12/2019 |
| 05/20/2019 | Seagen Inc. | SGEN | Grant | | 3k | $0.00 | $0 | | 05/20/2019 |
| 05/20/2019 | Seagen Inc. | SGEN | Grant | Non-Qualified Stock Option (right to buy) | 7k | $64.38 | $453.1k | | 05/20/2019 |
| 02/12/2019 | Syros Pharmaceuticals, Inc. | SYRS | Grant | Common Stock | 188k | $0.00 | $0 | | 02/12/2019 |
| 02/12/2019 | Syros Pharmaceuticals, Inc. | SYRS | Grant | Stock Option (right to buy) | 285k | $6.71 | $1.9M | | 02/12/2019 |
| 11/29/2018 | Syros Pharmaceuticals, Inc. | SYRS | Exercise | Stock Option (right to buy) | 12.1k | $3.04 | $36.7k | | 11/29/2018 |
| 11/29/2018 | Syros Pharmaceuticals, Inc. | SYRS | Exercise | Stock Option (right to buy) | 75k | $1.01 | $75.8k | | 11/29/2018 |
| 11/29/2018 | Syros Pharmaceuticals, Inc. | SYRS | Exercise | Stock Option (right to buy) | 23.5k | $1.01 | $23.7k | | 11/29/2018 |
| 05/18/2018 | Seagen Inc. | SGEN | Grant | | 3.7k | $0.00 | $0 | | 05/18/2018 |
|